EntrepreneurialCheck
Celestin de Wergifosse estimated net worth profile

Celestin de Wergifosse net worth

Celestin de Wergifosse Net Worth 2026 (Estimated) · Founder at Signatur Biosciences · YC S22
est. wealth $35.0M

Quick answer

Celestin de Wergifosse's estimated net worth is $35.0M (range $24.5M – $52.5M) as of 2026. Celestin de Wergifosse is Founder at Signatur Biosciences. Signatur Biosciences valuation.

Celestin de Wergifosse is Founder at Signatur Biosciences (YC S22). Independent Entrepreneurial Check model estimate from public YC data.

At a glance

NameCelestin de Wergifosse
RoleFounder
CompanySignatur Biosciences
YC batchS22
Est. company val$70.0M
Assumed ownership50%
Est. paper wealth / net worth$35.0M
$24.5M – $52.5M
  • Company status: Active
  • Region: United Kingdom
  • Industries: Healthcare, Diagnostics
  • Team size: 5
  • Website: https://www.signatur.bio/

Who is Celestin de Wergifosse?

Celestin de Wergifosse is a founder of Signatur Biosciences, which participated in Y Combinator's Summer 2022 batch.

Highlights:

  • Y Combinator S22
  • Signatur Biosciences
  • biotechnology sector

About Signatur Biosciences

We make precision diagnostics more accessible, starting with breast cancer prognosis. Current tests that guide the use of therapy are really slow and expensive because they need to be run in complex centralized facilities. Our tests are designed to be easily run by local hospital labs, reducing turnaround time from over three weeks to a few days and for a fraction of the price.

FAQ: Celestin de Wergifosse net worth and Signatur Biosciences valuation

What is Celestin de Wergifosse's net worth?

Celestin de Wergifosse's estimated net worth is $35.0M (range $24.5M – $52.5M) as of 2026. Celestin de Wergifosse is Founder at Signatur Biosciences. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.

What is Signatur Biosciences valuation?

Signatur Biosciences's estimated valuation on Entrepreneurial Check is $70.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.

What is Celestin de Wergifosse's role?

Celestin de Wergifosse is Founder at Signatur Biosciences, a Y Combinator-backed startup (batch S22).